Long- Term Uveitis Rates With Bimekizumab (BKZ) Treatment Across Pooled Phase 2b and Phase 3 Studies in Patients With Axial Spondyloarthritis (axSpA) or Psoriatic Arthritis (PsA): 3- Year Update

Bimzelx (bimekizumab-bkzx) - UCB

https://static1.squarespace.com/static/6642bbced8b22f3bcd7949a5/t/6a05b7ce0e0e4a17617431e0/1778759630269/APL_v29_iS2_Rev4.pdf

Drew Yates1; Martin Rudwaleit2; Irene E. van der Horst- Bruinsma3; Floris A. van Gaalen4; Nigil Haroon5; Lianne S. Gensler6; Myriam Manente7; Chetan Prajapati8; Katy White8; Atul Deodhar9; Matthew A. Brown10

May 26, 2026